Loading clinical trials...
Loading clinical trials...
Empathic Engagement With the COVID-19 Vaccine Hesitant in Private Facebook Groups
As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
Yes
George Washington University
Washington D.C., District of Columbia, United States
Start Date
January 17, 2022
Primary Completion Date
April 4, 2022
Completion Date
April 4, 2022
Last Updated
June 21, 2022
508
ACTUAL participants
Gist messages on COVID-19 vaccination
BEHAVIORAL
COVID-19 vaccine information
BEHAVIORAL
Lead Sponsor
George Washington University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06631287